179 related articles for article (PubMed ID: 21658141)
1. Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation.
Quaak M; van Schayck CP; Postma DS; Wagena EJ; van Schooten FJ
Addiction; 2012 Jan; 107(1):178-87. PubMed ID: 21658141
[TBL] [Abstract][Full Text] [Related]
2. The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients.
Van Schayck CP; Kaper J; Wagena EJ; Wouters EF; Severens JL
Addiction; 2009 Dec; 104(12):2110-7. PubMed ID: 19922576
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease.
Wagena EJ; Knipschild PG; Huibers MJ; Wouters EF; van Schayck CP
Arch Intern Med; 2005 Oct; 165(19):2286-92. PubMed ID: 16246996
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results.
Haggsträm FM; Chatkin JM; Sussenbach-Vaz E; Cesari DH; Fam CF; Fritscher CC
Pulm Pharmacol Ther; 2006; 19(3):205-9. PubMed ID: 16517193
[TBL] [Abstract][Full Text] [Related]
5. Antidepressants for smoking cessation.
Hughes JR; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2007 Jan; (1):CD000031. PubMed ID: 17253443
[TBL] [Abstract][Full Text] [Related]
6. Nortriptyline for smoking cessation: a review.
Hughes JR; Stead LF; Lancaster T
Nicotine Tob Res; 2005 Aug; 7(4):491-9. PubMed ID: 16085520
[TBL] [Abstract][Full Text] [Related]
7. Psychological intervention and antidepressant treatment in smoking cessation.
Hall SM; Humfleet GL; Reus VI; Muñoz RF; Hartz DT; Maude-Griffin R
Arch Gen Psychiatry; 2002 Oct; 59(10):930-6. PubMed ID: 12365880
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care.
Fossati R; Apolone G; Negri E; Compagnoni A; La Vecchia C; Mangano S; Clivio L; Garattini S;
Arch Intern Med; 2007 Sep; 167(16):1791-7. PubMed ID: 17846399
[TBL] [Abstract][Full Text] [Related]
9. Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia.
Bloch B; Reshef A; Cohen T; Tafla A; Gathas S; Israel S; Gritsenko I; Kremer I; Ebstein RP
Psychiatry Res; 2010 Jan; 175(1-2):38-42. PubMed ID: 19995670
[TBL] [Abstract][Full Text] [Related]
10. Bupropion for smoking cessation in patients hospitalized with acute myocardial infarction: a randomized, placebo-controlled trial.
Eisenberg MJ; Grandi SM; Gervais A; O'Loughlin J; Paradis G; Rinfret S; Sarrafzadegan N; Sharma S; Lauzon C; Yadav R; Pilote L;
J Am Coll Cardiol; 2013 Feb; 61(5):524-32. PubMed ID: 23369417
[TBL] [Abstract][Full Text] [Related]
11. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
Weiner E; Ball MP; Buchholz AS; Gold JM; Evins AE; McMahon RP; Buchanan RW
J Clin Psychiatry; 2012 Jan; 73(1):95-102. PubMed ID: 21535998
[TBL] [Abstract][Full Text] [Related]
12. A bupropion smoking cessation clinical trial for cancer patients.
Schnoll RA; Martinez E; Tatum KL; Weber DM; Kuzla N; Glass M; Ridge JA; Langer C; Miyamoto C; Wileyto EP; Leone F
Cancer Causes Control; 2010 Jun; 21(6):811-20. PubMed ID: 20087643
[TBL] [Abstract][Full Text] [Related]
13. CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial.
Lee AM; Jepson C; Hoffmann E; Epstein L; Hawk LW; Lerman C; Tyndale RF
Biol Psychiatry; 2007 Sep; 62(6):635-41. PubMed ID: 17223085
[TBL] [Abstract][Full Text] [Related]
14. Antidepressants for smoking cessation.
Hughes J; Stead L; Lancaster T
Cochrane Database Syst Rev; 2004 Oct; (4):CD000031. PubMed ID: 15494986
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling.
McCarthy DE; Piasecki TM; Lawrence DL; Jorenby DE; Shiffman S; Fiore MC; Baker TB
Nicotine Tob Res; 2008 Apr; 10(4):717-29. PubMed ID: 18418793
[TBL] [Abstract][Full Text] [Related]
16. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
Jorenby DE; Leischow SJ; Nides MA; Rennard SI; Johnston JA; Hughes AR; Smith SS; Muramoto ML; Daughton DM; Doan K; Fiore MC; Baker TB
N Engl J Med; 1999 Mar; 340(9):685-91. PubMed ID: 10053177
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of bupropion therapy for smoking cessation during routine clinical use.
Paluck EC; McCormack JP; Ensom MH; Levine M; Soon JA; Fielding DW
Ann Pharmacother; 2006 Feb; 40(2):185-90. PubMed ID: 16434561
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
[TBL] [Abstract][Full Text] [Related]
19. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
[TBL] [Abstract][Full Text] [Related]
20. Sustained-release bupropion for smoking cessation in a Chinese sample: a double-blind, placebo-controlled, randomized trial.
Sheng LX; Tang YL; Jiang ZN; Yao CH; Gao JY; Xu GZ; Tong XY
Nicotine Tob Res; 2013 Feb; 15(2):320-5. PubMed ID: 22614545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
